Cardiogenic shock

Etiology

• 5-10% of STEMIs

Management

RV failure

• Dobutamine Heart block
• Isoproterenol as bridge to pacemaker Norepinephrine
• Toxic effect on myocytes
• But still first-line 0.01-0.3 mcg/kg/min Milrinone (phosphodiesterase inhibitor)
• Should be avoided in acute STEMI shock

Prognosis

• 70% mortality